BLUEPRINT MEDICINES CORPORATION Increase (Decrease) in Deferred Revenue
BLUEPRINT MEDICINES CORPORATION reported Increase (Decrease) in Deferred Revenue of -$11.86 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-02-21
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$1.40M.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$4.63M.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was -$2.81M.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was -$3.02M, a 106.99% decline year-over-year.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in deferred revenue for fiscal 2017 was -$11.86M, a 135.31% decline from fiscal 2016.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in deferred revenue for fiscal 2016 was $33.59M, a 146.27% increase from fiscal 2015.
- BLUEPRINT MEDICINES CORPORATION increase (decrease) in deferred revenue for fiscal 2015 was $13.64M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$6.03M derived: sum of 2 quarters · filed 2018-02-21 | -$8.85M derived: sum of 3 quarters · filed 2018-02-21 | -$11.86M 10-K · filed 2018-02-21 |
| 2017-09-30 | -$4.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$7.45M derived: sum of 2 quarters · filed 2017-10-31 | -$10.46M 10-Q · filed 2017-10-31 | -$14.58M derived: sum of 4 quarters · filed 2018-02-21 |
| 2017-06-30 | -$2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$5.83M 10-Q · filed 2017-08-02 | -$9.94M derived: sum of 3 quarters · filed 2018-02-21 | -$11.65M derived: sum of 4 quarters · filed 2018-02-21 |
| 2017-03-31 | -$3.02M 10-Q · filed 2017-05-03 | -$7.13M derived: sum of 2 quarters · filed 2018-02-21 | -$8.83M derived: sum of 3 quarters · filed 2018-02-21 | -$12.55M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-12-31 | -$4.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$5.82M derived: sum of 2 quarters · filed 2018-02-21 | -$9.53M derived: sum of 3 quarters · filed 2018-02-21 | $33.59M 10-K · filed 2018-02-21 |
| 2016-09-30 | -$1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$5.42M derived: sum of 2 quarters · filed 2017-10-31 | $37.71M 10-Q · filed 2017-10-31 | $36.49M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-06-30 | -$3.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $39.41M 10-Q · filed 2017-08-02 | $38.19M derived: sum of 3 quarters · filed 2018-02-21 | $37.23M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-03-31 | $43.13M 10-Q · filed 2017-05-03 | $41.91M derived: sum of 2 quarters · filed 2018-02-21 | $40.95M derived: sum of 3 quarters · filed 2018-02-21 | $41.94M derived: sum of 4 quarters · filed 2018-02-21 |
| 2015-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$2.18M derived: sum of 2 quarters · filed 2018-02-21 | -$1.19M derived: sum of 3 quarters · filed 2018-02-21 | $13.64M 10-K · filed 2018-02-21 |
| 2015-09-30 | -$957.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $29.00K derived: sum of 2 quarters · filed 2016-11-10 | $14.86M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $986.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $15.82M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $14.83M 10-Q · filed 2016-05-10 |